tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Revenue

Compare
1 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Revenue

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had a revenue of 1.39B in the quarter ending Mar 31, 2025, with 15.06%. This bring the company's revenue in the last twelve months to 5.30B, Decreased 0.40%. In the fiscal year ending Dec 31, 2024, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had annual revenue of 5.28B with -3.03% growth.
Revenue (ttm)
5.30B
Revenue Growth
-5.05%
P/S Ratio
3.44
Revenue/Employee
HK$2,741,803
Employees
1,926
Market Cap
HK$18.16B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
5.28B-164.86M-3.03%
Dec 31, 2023
5.45B-1.71B-23.94%
Dec 31, 2022
7.16B794.23M+12.48%
Dec 31, 2021
6.37B1.03B+19.38%
Dec 31, 2020
5.33B707.42M+15.30%
Dec 31, 2019
4.62B-190.31M-3.95%
Dec 31, 2018
4.81B2.14B+80.32%
Dec 31, 2017
2.67B409.27M+18.10%
Dec 31, 2016
2.26B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis